A trial looking at different types of immunotherapy to have with chemotherapy and radiotherapy for locally advanced lung cancer (CheckMate 73L)

This trial is looking at adding nivolumab to chemoradiotherapy and comparing it to chemoradiotherapy alone.

It is also comparing 3 different immunotherapy treatments to have after these first treatments. These are nivolumab plus ipilumumab, nivolumab on its own and durvalumab.

It is for people with locally advanced lung cancer.